• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Tango Therapeutics, Inc. - Common Stock (NQ:TNGX)

    12.86 +0.12 (+0.98%)
    Streaming Delayed Price Updated: 11:04 AM EST, Feb 24, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 870,912
    Open 12.70
    Bid (Size) 12.82 (300)
    Ask (Size) 12.89 (100)
    Prev. Close 12.73
    Today's Range 12.64 - 13.07
    52wk Range 1.030 - 13.60
    Shares Outstanding 88,406,523
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    The $20 Billion Question: Revolution Medicines Surges as Big Pharma Circles the Pan-RAS Leader
    The first week of 2026 has set the biotech sector ablaze, with Revolution Medicines (NASDAQ: RVMD) finding itself at the epicenter of a high-stakes acquisition tug-of-war. Shares of the Redwood... 
    Via MarketMinute
    Topics Intellectual Property
    News headline image
    TANGO THERAPEUTICS INC (NASDAQ:TNGX) Posts Strong Q3 Earnings Beat Amid Mixed Market Reaction ↗
    Tango Therapeutics (TNGX) reported a strong Q3, beating revenue and EPS estimates. Despite the earnings beat, the stock saw mixed market reaction. 
    Via Chartmill
    Topics Earnings

    Performance

    YTD
    +44.0%
    +44.0%
    1 Month
    +10.1%
    +10.1%
    3 Month
    +24.4%
    +24.4%
    6 Month
    +91.3%
    +91.3%
    1 Year
    +447.0%
    +447.0%

    More News

    Read More
    News headline image
    Earnings Scheduled For November 4, 2025 ↗
    Via Benzinga
    News headline image
    A Peek at Tango Therapeutics's Future Earnings ↗
    Via Benzinga
    News headline image
    Earnings Scheduled For August 5, 2025 ↗
    Via Benzinga
    News headline image
    Earnings Scheduled For May 12, 2025 ↗
    Via Benzinga
    News headline image
    Insights into Tango Therapeutics's Upcoming Earnings ↗
    Via Benzinga
    News headline image
    Unveiling 5 Analyst Insights On Tango Therapeutics ↗
    Via Benzinga
    News headline image
    The Analyst Landscape: 5 Takes On Tango Therapeutics ↗
    Via Benzinga
    News headline image
    Is Tango Therapeutics Stock a Buy, Sell, or Hold After Major Shareholder Third Rock Ventures Sold Nearly Half a Million Shares? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Tango Therapeutics Touts Encouraging Data From Early-Stage Cancer Trial, Raises Capital To Fund Advancement ↗
    Via Benzinga
    News headline image
    Wondering what's happening in today's pre-market session? ↗
    Via Chartmill
    News headline image
    Tango Therapeutics Stock Soars Pre-Market On $225M Financing, Positive Study Data For Cancer Therapy ↗
    Via Stocktwits
    News headline image
    12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Tango (TNGX) Q2 Revenue Drops 52% ↗
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    Tango Therapeutics Inc (NASDAQ:TNGX) Reports Q2 2025 Earnings: Revenue Misses, EPS Meets Expectations Amid Clinical Progress ↗
    Via Chartmill
    News headline image
    5 Biotech Stocks with Highly Anticipated Pending Results ↗
    Via Stocktwits
    Topics Intellectual Property
    News headline image
    Sarepta Therapeutics, KULR Technology Group And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Quanex Building Products, Manchester United, Byrna Technologies And Other Big Stocks Moving Higher On Friday ↗
    Via Benzinga
    News headline image
    What's going on in today's session ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Thursday's After-Market Session ↗
    Via Benzinga
    News headline image
    Which stocks are experiencing notable movement on Monday? ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Monday's Intraday Session ↗
    Via Benzinga
    News headline image
    Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Tango Therapeutics, Inc.
    Via Business Wire
    News headline image
    Tango Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference
    From Tango Therapeutics, Inc.
    Via Business Wire

    Frequently Asked Questions

    Is Tango Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Tango Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Tango Therapeutics, Inc. - Common Stock trade on?
    Tango Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Tango Therapeutics, Inc. - Common Stock?
    The ticker symbol for Tango Therapeutics, Inc. - Common Stock is TNGX on the Nasdaq Stock Market
    What is the current price of Tango Therapeutics, Inc. - Common Stock?
    The current price of Tango Therapeutics, Inc. - Common Stock is 12.86
    When was Tango Therapeutics, Inc. - Common Stock last traded?
    The last trade of Tango Therapeutics, Inc. - Common Stock was at 02/24/26 11:04 AM ET
    What is the market capitalization of Tango Therapeutics, Inc. - Common Stock?
    The market capitalization of Tango Therapeutics, Inc. - Common Stock is 1.14B
    How many shares of Tango Therapeutics, Inc. - Common Stock are outstanding?
    Tango Therapeutics, Inc. - Common Stock has 1B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.